An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study | Elite Sports MagSkip to content
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study
The Training Science Trials Ledger follows ClinicalTrials.gov studies of exercise and training interventions, with training and population families, randomization and sponsor flags and completion horizons, drawn from the public ClinicalTrials.gov API and refreshed weekly. Entries summarize registered studies; no medical advice is given or implied.
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study
Status
RECRUITING
Training Family
exercise (general)
Population Family
clinical population
Is Recruiting
true
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study
The Training Science Trials Ledger follows ClinicalTrials.gov studies of exercise and training interventions, with training and population families, randomization and sponsor flags and completion horizons, drawn from the public ClinicalTrials.gov API and refreshed weekly. Entries summarize registered studies; no medical advice is given or implied.
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study